非裔美国女性全乳放疗急性放射性皮炎与食管炎的预测因素
本研究基于单中心2013—2019年272例接受辅助全乳放疗的非裔美国乳腺癌或导管原位癌患者,分析急性放射性皮炎(RD)和食管炎(RE)的预测因素。多因素分析显示乳房体积较大与G2及以上RD发生率更高相关,俯卧位和低分次放疗可降低G2RD;接受区域淋巴结照射者中19%发生G2RE,食管平均剂量(Dmean)是最佳预测因素。
要点
- 乳房体积较大与G2及以上放射性皮炎风险升高相关,且不受BMI影响。
- 俯卧位放疗和低分次放疗与G2RD发生率降低相关。
- 区域淋巴结照射亚组中19%发生G2RE,食管Dmean是最佳预测因素。
核心结论
- 在非裔美国患者中,乳房体积较大与G2及以上放射性皮炎发生率更高相关,食管Dmean是与G2RE最相关的剂量学参数。
研究设计与样本
- 单中心回顾性队列研究,纳入2013—2019年接受辅助全乳放疗的非裔美国乳腺癌或导管原位癌患者272例。
主要发现
- 单因素分析中,病态肥胖患者更易发生G2RD,低分次放疗与G2RD发生率较低相关。
- 多因素分析中,乳房体积较大与G2RD发生率更高相关。
- 接受区域淋巴结照射的患者中19%发生G2RE,多因素分析中食管Dmean是最佳预测因素。
关键数值与推荐
- 以放疗期间或结束后立即处方Silvadene或Mylanta-lidocaine分别作为G2及以上RD或RE的替代指标。
临床怎么用
- 可依据乳房体积、是否区域淋巴结照射及食管Dmean识别G2及以上毒性高风险患者。
- 对高风险患者可考虑俯卧位定位和低分次放疗以降低G2RD风险。
局限性
- 为单中心回顾性研究,G2及以上RD和RE以处方药物作为替代指标,非直接毒性分级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Adjuvant whole breast radiation therapy after breast-conserving surgery is the standard of care in the management of early-stage breast cancer. Two of the most common acute toxicities of breast radiation therapy are radiation esophagitis (RE) and radiation dermatitis (RD). African American individuals are at higher risk for experiencing treatment-related toxic effects and are often underrepresented in clinical trials. METHODS AND MATERIALS: An institutional database was developed to include all African American patients with a history of breast cancer or ductal carcinoma in situ undergoing adjuvant radiation therapy at a single institution from 2013 to 2019. Records were reviewed to identify patient age, body mass index (BMI), radiation dose, prone versus supine position, inclusion of boost, and inclusion of regional nodal irradiation. Radiation treatment plans were reviewed to identify breast size as well as dosimetric parameters to the breast and esophagus. Medical records were reviewed to identify which patients were prescribed Silvadene or Mylanta-lidocaine during or immediately after their course of radiation therapy, which was used as a surrogate for grade 2 (G2) or higher RD or RE, respectively. RESULTS: A total of 272 patients were included in the final analysis. On univariable analysis, patients with morbid obesity were more likely to develop G2RD, whereas hypofractionated radiation therapy was associated with lower rates of G2RD. On multivariable analysis, greater breast volume was associated with higher rates of G2RD. In the subset of patients receiving regional node irradiation, 19% of the patients experienced G2RE, and the best predictor on multivariable analysis was the mean radiation dose (Dmean) to the esophagus. CONCLUSIONS: Radiation dermatitis and esophagitis are common toxic effects in African American patients undergoing adjuvant breast radiation therapy. In this study, greater breast size, irrespective of the patient's BMI, was associated with a higher rate of dermatitis. Prone positioning during treatment and hypofractionated radiation reduced rates of G2RD. The Dmean to the esophagus was the dosimetric parameter most correlated with G2RE. These results may be used to help select patients at higher risk for toxic effects of G2 or greater during radiation therapy.
引用
- Dzul S, Ninia J, Jang H, et al. Predictors of Acute Radiation Dermatitis and Esophagitis in African American Patients Receiving Whole-Breast Radiation Therapy. Pract Radiat Oncol. 2021. PMID: 34710629. doi:10.1016/j.prro.2021.08.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。